Quidel Corp (QDEL)

246.64 +1.68  +0.69% NASDAQ Jul 10, 20:00 Delayed 2m USD
View Full Chart
Price Chart
View All Events


Date Type Description
08/07/2020 17:00 EDT Misc Quidel Corp Second Quarter Earnings Conference Call in 2020
08/07/2020 Earnings Quidel Corp Second Quarter Earnings in 2020 Release
05/12/2020 08:30 PDT Misc Quidel Corp Annual General Meeting for 2019
05/06/2020 17:00 EDT Misc Quidel Corp First Quarter Earnings Conference Call for 2020
05/06/2020 Earnings Quidel Corp First Quarter Earnings Result for 2020
02/13/2020 Misc Quidel Corp Annual Report for 2019
02/12/2020 17:00 EST Misc Quidel Corp Fourth Quarter Earnings Conference Call for 2019
02/12/2020 Earnings Quidel Corp Fourth Quarter Earnings in 2019 Release
10/30/2019 05:00 EDT Misc Quidel Corp Third Quarter Earnings Conference Call for 2019
10/30/2019 Earnings Quidel Corp Third Quarter Earnings for 2019 Release
View All Performance Charts

Total Returns Comparison

Ratings & Reports



  • URL: http://www.quidel.com
  • Investor Relations URL: http://phx.corporate-ir.net/phoenix.zhtml?c=94060&p=irol-irhome
  • HQ State/Province: California
  • Sector: Healthcare
  • Industry: Diagnostics & Research
  • Equity Style: Mid Cap/Growth
  • Next Earnings Release: Aug. 07, 2020
  • Last Earnings Release: May. 06, 2020
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: Quidel Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. It is separated into four product categories: Rapid immunoassays, Cardiac immunoassays, Specialized diagnostic solutions and Molecular diagnostic solutions. Rapid immunoassay and Cardiac immunoassay tests for use in physician offices, hospital laboratories and emergency departments, retail clinics, eye health settings, pharmacies and other urgent care sites, Specialized diagnostic solutions, including direct fluorescent assays and culture-based tests, and Molecular diagnostic tests across a number of hospitals, moderately complex physician offices, laboratories and other segments. The company generates a majority of its revenue from the rapid immunoassays.

Top Fund Holders

Symbol Name Weighting
BCSIX Brown Capital Mgmt Small Co Inv 5.79%
PTH Invesco DWA Healthcare Momentum ETF 5.14%
AOFYX Alger Small Cap Focus Y 5.04%
FXH First Trust Health Care AlphaDEX® ETF 2.09%
FSMEX Fidelity® Select Medical Tech and Devcs 1.81%
DCCRX Delaware Small Cap Core R 1.63%
PASVX T. Rowe Price Small-Cap Value Adv 1.37%
PASSX T. Rowe Price Small-Cap Stock Adv 1.27%
IJK iShares S&P Mid-Cap 400 Growth ETF 1.07%
MDYG SPDR® S&P 400 Mid Cap Growth ETF 1.07%
IJH iShares Core S&P Mid-Cap ETF 0.61%
SCHA Schwab US Small-Cap ETF™ 0.37%





Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.